metricas
covid
Buscar en
Clínica e Investigación en Ginecología y Obstetricia
Toda la web
Inicio Clínica e Investigación en Ginecología y Obstetricia Sarcoma indiferenciado de ovario
Journal Information
Vol. 31. Issue 8.
Pages 297-301 (January 2004)
Share
Share
Download PDF
More article options
Vol. 31. Issue 8.
Pages 297-301 (January 2004)
Full text access
Sarcoma indiferenciado de ovario
Visits
13467
J. López-Olmosa, P. Navarrob
a Servicio de Ginecología. Hospital Arnau de Vilanova. Valencia. España
b Servicio de Anatomía Patológica. Hospital Arnau de Vilanova. Valencia. España
This item has received
Article information
Resumen

Presentamos un caso clínico de sarcoma indiferenciado de ovario en una mujer de 60 años, que falleció al mes de la intervención (biopsias más omentectomía),antes de recibir quimioterapia. Los sarcomas de ovario son tumores raros,muy malignos y con pocasupervivencia.

Abstract

We present the clinical case of undifferentiated ovarian sarcoma in a 60 years old women, who died one month after surgery (biopsies and omentectomy), before receiving chemotherapy. Ovarian sarcomas are very rare tumors, very malignant and with poor survival.

Full text is only aviable in PDF
Bibliografía
[1.]
R.E. Scully, R.E. Young, PhB. Clement.
Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament.
Atlas of tumor pathology. Fascicle 23. Third series,
[2.]
J.S. Berek, Y.S. Fu, N.F. Hacker.
Cáncer ovárico.
Ginecología de Novak, 12.a, pp. 1211-1212
[3.]
P. Russell, S.J. Robboy, M.C. Anderson.
Sarcomas not otherwise differentiated.
Pathology of the female. Reproductive tract, pp. 694
[4.]
B. Anderson, D.A. Turner, J. Benda.
Ovarian sarcoma.
Gynecol Oncol, 26 (1987), pp. 183-192
[5.]
S.M. Shakfeh, J.D. Woodruff.
Primary ovarian sarcoma: report of 46 cases and review of the literature.
Obstet Gynecol Surv, 42 (1987), pp. 331-349
[6.]
A.K. Sood, J.I. Sorosky, M.S. Gelder, R.E. Buller, B. Anderson, E.J. Wilkinson, et al.
Primary ovarian sarcoma. Analysis of prognostic variables and the role of surgical cytoreduction.
Cancer, 82 (1988), pp. 1731-1737
[7.]
B. Piura, A. Rabinovich, I. Yanai-Inbar, Y. Cohen, M. Glezerman.
Primary sarcoma of the ovary: report of five cases and review of the literature.
Eur J Gynecol Oncol, 19 (1998), pp. 257-261
[8.]
T. Hirakawa, M. Tsuneyoshi, M. Enjoji, R. Shigyo.
Ovarian sarcoma with histologic features of telangiectatic osteosarcoma of the bone.
Am J Surg Pathol, 12 (1988), pp. 567-572
[9.]
J. López-Olmos, P. Navarro.
Metástasis en ovarios de angiosarcoma.
Clin Invest Ginecol Obst, 26 (1999), pp. 188-193
[10.]
T.R. Baker, M.S. Piver, H. Caglar, H. Piedmonte.
Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcoma of the uterus and ovary.
Am J Clin Oncol, 14 (1991), pp. 246-250
[11.]
B. Patsner, S. Greenberg.
Mesna, doxorrubicin, ifosfamide and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
Gynecol Oncol, 58 (1995), pp. 386-388
[12.]
A. Sahin, J.A. Benda.
An immunohistochemical study of primary ovarian sarcoma. An evaluation of nine tumors.
Int J Gynecol Pathol, 7 (1988), pp. 268-279
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos